Evofem Biosciences EVFM
OTC EVFM
$0.01 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Evofem Biosciences (EVFM) Short term Debt (2015 - 2016)

Updated

Evofem Biosciences (EVFM) recorded Short term Debt of $1.19 million in Q2 2016, down 3.1% from $1.23 million a year earlier but up 51.6% from the prior quarter.

Analysis

Evofem Biosciences (EVFM) Short term Debt (2015 - 2016) Analysis & Trends

At the end of FY2015, Evofem Biosciences reported Short term Debt of $2.76 million.

  • Quarterly Short term Debt has ranged from $487,738 in Q1 2015 to $2.76 million in Q4 2015 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $785,123 (Q1 2016), $2.76 million (Q4 2015) and $1.99 million (Q3 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,171.71 Bn 1,140.30 Bn 19.71 Bn
2 Johnson & Johnson 642.13 Bn 560.65 Bn 17.26 Bn
3 AbbVie 501.64 Bn 474.75 Bn 12.70 Bn
4 Merck 375.66 Bn 330.04 Bn 12.21 Bn
5 Novartis Ag 302.79 Bn 266.78 Bn 11.24 Bn
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn
8 Gilead Sciences 193.69 Bn 167.89 Bn 6.22 Bn
9 Pfizer 172.47 Bn 119.12 Bn 10.94 Bn
10 Evofem Biosciences 1.33 Mn 1.33 Mn 2.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 1.19 Mn
Mar 31, 2016 785,123.00
Dec 31, 2015 2.76 Mn
Sep 30, 2015 1.99 Mn
Jun 30, 2015 1.23 Mn
Mar 31, 2015 487,738.00
API Access

Evofem Biosciences Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=EVFM&period=max&api_key=YOUR_API_KEY